From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
0–5 years of follow-up
5 years to end of follow-up
Variable: pathology type
HR (95 % CI)
P-value
DFS
IDC
1.0
ILC
1.32(0.64–2.72)
0.440
7.42(2.94–18.74)
<0.001
OS
2.74(0.95–7.91)
0.051
2.09(0.48–9.01)
0.308